Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3174615

CN1CCN(C(=O)C2CCN(Cc3ccc(C(=O)NN(c4nc(C#N)ncc4Br)C4CCCC4)cc3)CC2)CC1.O=C(O)C(F)(F)F

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CTSS P25774 4/20 0.58
CTSK P43235 4/20 0.58
CTSL P07711 3/20 0.58
CTSB P07858 1/20 0.58
PRKAA2 P54646 9/20 0.41
PRKAB2 O43741 6/20 0.36
PRKAG1 P54619 6/20 0.36
PRKAA1 Q13131 6/20 0.36
PRKAG3 Q9UGI9 6/20 0.36
PRKAG2 Q9UGJ0 6/20 0.36
PRKAB1 Q9Y478 6/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
KMT2A Q03164 2/20 0.36
HDAC6 Q9UBN7 1/20 0.36
CYP3A4 P08684 1/20 0.36
MEN1 O00255 1/20 0.35
TSHR P16473 1/20 0.35
CHRM4 P08173 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3165193 0.99 CTSS (0.57) CTSSCTSKCTSLCTSBPRKAA2
SCHEMBL3169210 0.95 CTSS (0.63) CTSSCTSKCTSLCTSBPRKAA2
Trifluoroacetic Acid SCHEMBL3165464 0.95 CTSS (0.55) CTSSCTSKCTSLCTSBPRKAA2
Trifluoroacetic Acid SCHEMBL3165907 0.95 CTSS (0.55) CTSSCTSKCTSLCTSBPRKAA2
SCHEMBL3179568 0.94 CTSS (0.62) CTSSCTSKCTSLCTSBPRKAA2
Trifluoroacetic Acid SCHEMBL3174605 0.94 CTSS (0.65) CTSSCTSKCTSLCTSBHDAC6
Trifluoroacetic Acid SCHEMBL3180549 0.93 CTSS (0.64) CTSSCTSKCTSLCTSBHDAC6
Trifluoroacetic Acid SCHEMBL3172970 0.92 CTSS (0.48) CTSSCTSKCTSLCTSBCHRM4
Trifluoroacetic Acid SCHEMBL3175330 0.92 CTSS (0.48) CTSSCTSKCTSLCTSBPRKAA2
Trifluoroacetic Acid SCHEMBL3165929 0.91 CTSS (0.58) CTSSCTSKCTSLCTSBHDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100009956-A1 NOVEL SUBSTITUTED PYRIMIDINES AS CYSTEINE PROTEASE INHIBITORS Glaxo Group Limited , a corporation 2010-01-14 US claimed
EP-2030621-A1 Novel substituted pyrimidines as cysteine protease inhibitors GLAXO GROUP LIMITED (GB) 2009-03-04 EP claimed
EP-1947091-A1 Pyrimidyl nitrile derivatives as cysteine protease inhibitors GLAXO GROUP LIMITED (GB) 2008-07-23 EP claimed
EP-1918284-A1 Hydrazinopyrimidines as cysteine protease inhibitors GLAXO GROUP (GB) 2008-05-07 EP claimed
US-20100009956-A1 NOVEL SUBSTITUTED PYRIMIDINES AS CYSTEINE PROTEASE INHIBITORS Glaxo Group Limited , a corporation 2010-01-14 US disclosed
EP-2030621-A1 Novel substituted pyrimidines as cysteine protease inhibitors GLAXO GROUP LIMITED (GB) 2009-03-04 EP disclosed
EP-1947091-A1 Pyrimidyl nitrile derivatives as cysteine protease inhibitors GLAXO GROUP LIMITED (GB) 2008-07-23 EP disclosed
EP-1918284-A1 Hydrazinopyrimidines as cysteine protease inhibitors GLAXO GROUP (GB) 2008-05-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009956-A1 NOVEL SUBSTITUTED PYRIMIDINES AS CYSTEINE PROTEASE INHIBITORS SERPINB1, CTRL, PRSS1 CTSS 15/4885CTSK 65/4885CTSL 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.